Document is current
Any future updates will be listed below
-
Authors
Flanders, Lucy https://orcid.org/0009-0008-0778-596X
Savy, Thomas
Ficial, Miriam
Al-Ghraibawi, Narjis
Barber, Louise
Slater, Sarah
Pihlak, Rille
Propper, David
Begum, Sultana
Rodriguez-Justo, Manuel
Gerlinger, Marco https://orcid.org/0000-0003-2719-299X
- License Information
-
More Information
Article History
Received: 1 October 2025
Revised: 25 January 2026
Accepted: 10 March 2026
First Online: 18 April 2026
Competing interests
: MG received institutional research funding from Merck KGaA, Darmstadt, Germany, Bristol Myers Squibb and Roche, advisory fees from GSK, Roche and MSD and speaker fees and travel support from MSD, Roche, Merck KGaA, Darmstadt, Germany, Bristol Myers Squibb, Servier and Takeda. LF received advisory fees from BMS and speaker fees from BMS and Merck. SS received travel support AZD and advisory fees from Eisai. DP received honoraria from BPGbio and Bayer; advisory fees from BMS, BPGbio; speaker fees from Merck and Servier and travel support from Celgene. RP received honoraria from BPGbio and Bayer; advisory fees from BMS and BPGbio; speaker fees from Merck and Servier and travel support from Servier, Chugai, Bayer, Takeda and Celgene. MR received honorarium for symposium, advisory boards, educational meetings from Agilent, Gilead, BeOne, AstraZeneca and Roche Diagnostics.
